We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00455559
Recruitment Status : Completed
First Posted : April 3, 2007
Last Update Posted : February 21, 2018
M.D. Anderson Cancer Center
Information provided by (Responsible Party):
AEterna Zentaris

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2010
  Study Completion Date : October 2011
  Certification or Request for Extension to Delay Results Submission: February 6, 2018
Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No 15S (May 20 Supplement), 2009: 10563